ECML Euclidean Fundamental Value ETF

Expense Ratio
0.95%
Dividend
1.23%
Previous close
$37.32
Est. 12 months change
+8.37%
Projected Price
$40.44

Profitability Metrics

Return on Equity (ROE)
21.51%
Return on Assets (ROA)
9.38%
Return on Invested Capital (ROIC)
20.50%
Weighted Average Cost of Capital (WACC)
7.98%
ROIC - WACC
12.52%
Updated : 2026-04-08 19:40 ET

Valuation Metrics

P/E Ratio
12.50
Forward P/E
12.20
PEG Ratio
2.79
Debt Current Ratio
3.10

Growth & Cash Flow

Gross Margin
39.67%
Operating Margin
20.76%
FCF Margin
15.29%
TTM Revenue Growth
7.31%
Projected 12M EPS Growth
2.53%

Price Change

Price % from 50 SMA
3.09%
Price % from 200 SMA
10.55%
6 Months
12.29%
1 Year
37.97%
2 Years
9.77%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
PLAB2.55%
MLI2.53%
PRDO2.42%
APA2.42%
CF2.41%
OSK2.25%
MATX2.19%
FCX2.18%
ALSN2.16%
FOXA2.15%

ETF Analysis

Fund Overview

Euclidean Fundamental Value ETF (ECML) currently reports 63 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is PLAB (2.55%), MLI (2.53%), PRDO (2.42%), with PLAB as the largest single weight at 2.55%. Together, the top three holdings account for 7.50%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 20.50%, WACC is 7.98%, and the economic spread is 12.52%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 21.51% and ROA at 9.38%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The portfolio's current market valuation reflects trailing P/E of 12.50, forward P/E of 12.20, PEG of 2.79. The trailing-to-forward compression is minimal, consistent with a market that sees limited earnings acceleration from current levels. Growth-adjusted valuation is stretched here — the multiple implies either above-consensus growth or a willingness to pay a premium for quality. At 3.10, the aggregate current ratio reflects strong balance sheet liquidity across the portfolio. Across multiples and liquidity, the portfolio is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 39.67%, operating margin at 20.76%, and free cash flow margin at 15.29%. The gross margin reading is middling — acceptable, but leaving less room for error at the production level. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.

Growth & Forward Outlook

Projected 12-month EPS growth of 2.5% is a constructive signal — measured earnings expansion supports the forward valuation case without relying on aggressive extrapolation. Turning to growth and analyst expectations, TTM revenue growth of 7.31% pointing to stable operational progress without outsized acceleration, while the estimated 12-month price change of 8.45%, where street expectations indicate a low-ceiling return setup in the near term. The distinction matters: revenue growth tells you what the businesses are doing, price targets tell you what analysts think the market will pay for it. Ultimately, the alignment between revenue momentum and analyst targets will depend on execution quality and the broader rate and sentiment environment. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Taken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.